{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:52:23Z","timestamp":1793303543443,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Small-molecule modulators of TLR8 have drawn much interests as it plays pivotal roles in the innate immune response to single-stranded RNAs (ssRNAs) derived from viruses. However, their clinical uses are limited because they can invoke an uncontrolled, global inflammatory response. The efforts described herein culminate in the fortuitous discovery of a tetrasubstituted imidazole <jats:bold>CU-CPD107<\/jats:bold> which inhibits R848-induced TLR8 signaling. In stark contrast, <jats:bold>CU-CPD107<\/jats:bold> shows unexpected synergistic agonist activities in the presence of ssRNA, while <jats:bold>CU-CPD107<\/jats:bold> alone is unable to influence TLR8 signaling. <jats:bold>CU-CPD107<\/jats:bold>\u2019s unique, dichotomous behavior sheds light on a way to approach TLR agonists. <jats:bold>CU-CPD107<\/jats:bold> offers the opportunity to avoid the undesired, global inflammation side effects that have rendered imidazoquinolines clinically irrelevant, providing an insight for the development of antiviral drugs.<\/jats:p>","DOI":"10.1038\/s41467-021-24536-4","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T10:03:33Z","timestamp":1626429813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Tetrasubstituted imidazoles as incognito Toll-like receptor 8\u2009a(nta)gonists"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0277-6139","authenticated-orcid":false,"given":"Yi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Csakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Tanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torey","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sakaniwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Broadwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subada","family":"Soti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-4044","authenticated-orcid":false,"given":"Umeharu","family":"Ohto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-5365","authenticated-orcid":false,"given":"Shu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5385-083X","authenticated-orcid":false,"given":"Fei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0547-8922","authenticated-orcid":false,"given":"Toshiyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9762-4818","authenticated-orcid":false,"given":"Hang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"24536_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nri2079","volume":"7","author":"LA O\u2019Neill","year":"2007","unstructured":"O\u2019Neill, L. A. & Bowie, A. G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353\u2013364 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"24536_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805\u2013820 (2010).","journal-title":"Cell"},{"key":"24536_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ni0602-499","volume":"3","author":"M Jurk","year":"2002","unstructured":"Jurk, M. et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3, 499 (2002).","journal-title":"Nat. Immunol."},{"key":"24536_CR4","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1093620","volume":"303","author":"F Heil","year":"2004","unstructured":"Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526\u20131529 (2004).","journal-title":"Science"},{"key":"24536_CR5","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/eji.200526149","volume":"35","author":"K Triantafilou","year":"2005","unstructured":"Triantafilou, K. et al. TLR8 and TLR7 are involved in the host\u2019s immune response to human parechovirus 1. Eur. J. Immunol. 35, 2416\u20132423 (2005).","journal-title":"Eur. J. Immunol."},{"key":"24536_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1586\/14760584.2013.811208","volume":"12","author":"JP Vasilakos","year":"2013","unstructured":"Vasilakos, J. P. & Tomai, M. A. The use of Toll-like receptor 7\/8 agonists as vaccine adjuvants. Expert Rev. Vaccines 12, 809\u2013819 (2013).","journal-title":"Expert Rev. Vaccines"},{"key":"24536_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrmicro2745","volume":"10","author":"REW Hancock","year":"2012","unstructured":"Hancock, R. E. W., Nijnik, A. & Philpott, D. J. Modulating immunity as a therapy for bacterial infections. Nat. Rev. Microbiol. 10, 243\u2013254 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"24536_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2015.08.009","volume":"15","author":"MJ Jimenez-Dalmaroni","year":"2016","unstructured":"Jimenez-Dalmaroni, M. J., Gerswhin, M. E. & Adamopoulos, I. E. The critical role of toll-like receptors\u2013from microbial recognition to autoimmunity: a comprehensive review. Autoimmun. Rev. 15, 1\u20138 (2016).","journal-title":"Autoimmun. Rev."},{"key":"24536_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nri3095","volume":"11","author":"KH Mills","year":"2011","unstructured":"Mills, K. H. TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 11, 807\u2013822 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"24536_CR10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1182\/blood-2005-12-4821","volume":"108","author":"O Levy","year":"2006","unstructured":"Levy, O., Suter, E. E., Miller, R. L. & Wessels, M. R. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 108, 1284\u20131290 (2006).","journal-title":"Blood"},{"key":"24536_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/978-1-4615-1823-5_21","volume":"6","author":"JT Ulrich","year":"1995","unstructured":"Ulrich, J. T. & Myers, K. R. Monophosphoryl lipid A as an adjuvant. Past experiences and new directions. Pharm. Biotechnol. 6, 495\u2013524 (1995).","journal-title":"Pharm. Biotechnol."},{"key":"24536_CR12","doi-asserted-by":"publisher","first-page":"e01024","DOI":"10.1128\/mBio.01024-15","volume":"6","author":"BY Chua","year":"2015","unstructured":"Chua, B. Y. et al. Inactivated influenza vaccine that provides rapid, innate-immune-system-mediated protection and subsequent long-term adaptive immunity. mBio 6, e01024\u201301015 (2015).","journal-title":"mBio"},{"key":"24536_CR13","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1128\/JVI.03337-14","volume":"89","author":"PH Goff","year":"2015","unstructured":"Goff, P. H. et al. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. J. Virol. 89, 3221\u20133235 (2015).","journal-title":"J. Virol."},{"key":"24536_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.20051720","volume":"203","author":"T Querec","year":"2006","unstructured":"Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413\u2013424 (2006).","journal-title":"J. Exp. Med."},{"key":"24536_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1126\/scisignal.aaw1347","volume":"12","author":"M de Marcken","year":"2019","unstructured":"de Marcken, M., Dhaliwal, K., Danielsen, A. C., Gautron, A. S. & Dominguez-Villar, M. TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection. Sci. Signal 12, 2\u201318 (2019).","journal-title":"Sci. Signal"},{"key":"24536_CR16","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1182\/blood-2008-01-132860","volume":"112","author":"JP Wang","year":"2008","unstructured":"Wang, J. P. et al. Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112, 2028\u20132034 (2008).","journal-title":"Blood"},{"key":"24536_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/ni758","volume":"3","author":"H Hemmi","year":"2002","unstructured":"Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3, 196\u2013200 (2002).","journal-title":"Nat. Immunol."},{"key":"24536_CR18","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1126\/science.1229159","volume":"339","author":"H Tanji","year":"2013","unstructured":"Tanji, H., Ohto, U., Shibata, T., Miyake, K. & Shimizu, T. Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science 339, 1426\u20131429 (2013).","journal-title":"Science"},{"key":"24536_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nchembio.2518","volume":"14","author":"ST Zhang","year":"2018","unstructured":"Zhang, S. T. et al. Small-molecule inhibition of TLR8 through stabilization of its resting state. Nat. Chem. Biol. 14, 58\u201364 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"24536_CR20","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.chembiol.2018.07.004","volume":"25","author":"ZY Hu","year":"2018","unstructured":"Hu, Z. Y. et al. Small-molecule TLR8 antagonists via structure-based rational design. Cell Chem. Biol. 25, 1286 (2018).","journal-title":"Cell Chem. Biol."},{"key":"24536_CR21","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1021\/acs.jmedchem.9b02128","volume":"63","author":"S Jiang","year":"2020","unstructured":"Jiang, S. et al. Rationally designed small-molecule inhibitors targeting an unconventional pocket on the TLR8 protein-protein interface. J. Med. Chem. 63, 4117\u20134132 (2020).","journal-title":"J. Med. Chem."},{"key":"24536_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1021\/jm4004957","volume":"57","author":"CE Schiaffo","year":"2014","unstructured":"Schiaffo, C. E. et al. Structure-activity relationship analysis of imidazoquinolines with Toll-like receptors 7 and 8 selectivity and enhanced cytokine induction. J. Med. Chem. 57, 339\u2013347 (2014).","journal-title":"J. Med. Chem."},{"key":"24536_CR23","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1021\/acsmedchemlett.7b00256","volume":"8","author":"P Larson","year":"2017","unstructured":"Larson, P. et al. Design and synthesis of N1-modified imidazoquinoline agonists for selective activation of Toll-like receptors 7 and 8. ACS Med. Chem. Lett. 8, 1148\u20131152 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"24536_CR24","doi-asserted-by":"publisher","first-page":"e43612","DOI":"10.1371\/journal.pone.0043612","volume":"7","author":"NM Shukla","year":"2012","unstructured":"Shukla, N. M. et al. 3-potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer. PLoS ONE 7, e43612 (2012).","journal-title":"PLoS ONE"},{"key":"24536_CR25","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1039\/c3ob40816g","volume":"11","author":"E Yoo","year":"2013","unstructured":"Yoo, E. et al. 6-structure-activity relationships in Toll-like receptor 7 agonistic 1H-imidazo[4,5-c]pyridines. Org. Biomol. Chem. 11, 6526\u20136545 (2013).","journal-title":"Org. Biomol. Chem."},{"key":"24536_CR26","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1021\/acs.jmedchem.5b01087","volume":"58","author":"M Beesu","year":"2015","unstructured":"Beesu, M. et al. 8-structure-based design of human TLR8-specific agonists with augmented potency and adjuvanticity. J. Med. Chem. 58, 7833\u20137849 (2015).","journal-title":"J. Med. Chem."},{"key":"24536_CR27","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1021\/acs.jmedchem.6b00023","volume":"59","author":"M Beesu","year":"2016","unstructured":"Beesu, M. et al. Identification of a human Toll-like receptor (TLR) 8-specific agonist and a functional pan-TLR inhibitor in 2-aminoimidazoles. J. Med. Chem. 59, 3311\u20133330 (2016).","journal-title":"J. Med. Chem."},{"key":"24536_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.tet.2006.10.055","volume":"63","author":"R Torregrosa","year":"2007","unstructured":"Torregrosa, R., Pastor, I. M. & Yus, M. Solvent-free direct regioselective ring opening of epoxides with imidazoles. Tetrahedron 63, 469\u2013473 (2007).","journal-title":"Tetrahedron"},{"key":"24536_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1471-4906(02)02259-7","volume":"23","author":"M Rehli","year":"2002","unstructured":"Rehli, M. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 23, 375\u2013378 (2002).","journal-title":"Trends Immunol."},{"key":"24536_CR30","first-page":"7052","volume":"48","author":"AS Alharbi","year":"2020","unstructured":"Alharbi, A. S. et al. Rational design of antisense oligonucleotides modulating the activity of TLR7\/8 agonists. Nucleic Acids Res. 48, 7052\u20137065 (2020).","journal-title":"Nucleic Acids Res."},{"key":"24536_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nsmb.2943","volume":"22","author":"H Tanji","year":"2015","unstructured":"Tanji, H. et al. Toll-like receptor 8 senses degradation products of single-stranded RNA. Nat. Struct. Mol. Biol. 22, 109\u2013115 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"24536_CR32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0171-2985(84)80042-X","volume":"166","author":"AJ Ulmer","year":"1984","unstructured":"Ulmer, A. J., Scholz, W., Ernst, M., Brandt, E. & Flad, H. D. Isolation and subfractionation of human peripheral-blood mononuclear-cells (Pbmc) by density gradient centrifugation on percoll. Immunobiology 166, 238\u2013250 (1984).","journal-title":"Immunobiology"},{"key":"24536_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"24536_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1107\/S0907444909042589","volume":"66","author":"A Vagin","year":"2010","unstructured":"Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. D. Biol. Crystallogr. 66, 22\u201325 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"24536_CR35","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"24536_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D. Biol. Crystallogr. 53, 240\u2013255 (1997).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"24536_CR37","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"24536_CR38","unstructured":"Schr\u00f6dinger, L. L. C., New York. Schr\u00f6dinger Release 2018\u20131 (2018)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24536-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T13:33:42Z","timestamp":1669988022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-24536-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["24536"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-24536-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"16 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.Y. and S.J. have filed a patent application based on the technology reported in this manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4351"}}